Our Next Generation Sequencing (NGS) technology allows us to analyze DNA with high accuracy, sequencing it to over 99.9% analytical accuracy. This accuracy has been validated externally by The Croucher Laboratory for Human Genomics (CLHG), CUHK. Our NGS technology covers over 3 million data points, which can provide valuable insights into your and your family's health.
Many of our competitors rely on older genotyping technology, which misses approximately 98% of mutations for conditions like breast cancer. However, with our NGS technology, we can capture at minimum 5x more data, detecting novel mutations that may be missed by others in the Cancer Risk and Family Planning (carrier screening) panels.
In addition, all DNA categories tested in Circle are supported by extensive research conducted by renowned science and research institutes worldwide. We also adhere to the standards and guidelines set by the American College of Medical Genetics.